支架市场规模、份额和成长分析（按产品、材质、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，支架市场规模将达到 96.1 亿美元，到 2025 年将达到 99.2 亿美元，到 2033 年将达到 128.7 亿美元，在预测期（2026-2033 年）内，复合年增长率为 3.3%。

由于冠状动脉疾病（主要死因之一）的发生率不断上升，支架市场正经历强劲增长。对先进医疗干预措施（尤其是药物释放型支架）的需求不断增长，推动了市场扩张。技术创新不断改进支架的设计和疗效，而来自私人和政府机构的大量投资也为医疗研发注入了动力。支架的材质从塑胶到金属不等，它们在维持血流方面发挥着至关重要的作用，能够疏通动脉阻塞，预防动脉瘤等严重併发症。医疗技术的进步，加上心血管疾病发病率的不断上升，使得支架成为现代医疗保健的关键组成部分，并为相关人员提供了持续的机会，以有效满足患者的迫切需求。

支架市场成长要素

心血管疾病发生率的不断上升是支架市场成长的关键驱动因素。随着全球心血管疾病患者人数的增加，对支架的需求预计将会增加。慢性病盛行率的上升推动了医疗介入的需求，尤其是经皮冠状动脉介入治疗和周边血管手术。由于心血管疾病在全球死亡人数中占很大比例，因此对有效治疗方法的需求更加迫切。因此，随着越来越多的患者需要这些先进的手术，支架市场预计将大幅扩张，以满足不断增长的医疗需求。

支架市场的限制

由于严格的监管要求阻碍了支架市场的成长，该市场面临巨大的挑战。各监管机构制定了广泛的指导方针，以确保支架的安全有效使用，要求在核准前对现有文献和临床前动物研究进行全面审查。由于冠状动脉支架被归类为高风险医疗设备，这个过程尤其耗费资源，需要大量的时间和资金投入。鑑于相关风险，支架的使用受到严格审查，这进一步加剧了市场动态。将这些器械归类为中高风险产品增加了监管负担，并最终抑制了市场需求。

支架市场趋势

支架市场正经历显着成长，这主要得益于旨在改善患者预后的持续产品创新和改进。关键进展集中在降低支架梁厚度，以提高其在复杂血管解剖结构中的柔软性和输送性能，以及增加支架长度和直径，以优化经皮冠状动脉介入治疗（PCI）。这个动态趋势凸显了业界致力于改善支架设计、应对手术挑战并提升患者整体体验的决心。随着製造商加大研发投入以满足医疗服务提供者和患者不断变化的需求，预计未来几年这一增长势头将推动市场强劲扩张。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术进步
• 贸易分析

全球支架市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 血管
  • 冠状动脉支架
  • 外周支架
  • 髂动脉支架
  • 股动脉支架
  • 颈动脉支架
  • 肾动脉支架
  • 其他外周支架
  • 神经血管支架
  • 颅内支架
  • 分流器
• 非血管支架
  • 消化道支架
  • 胆道
  • 十二指肠
  • 结肠
  • 胰臟
  • 食道支架
  • 肺（气道）支架
  • 硅胶气道
  • 金属气道
  • 泌尿系统支架
  • 其他的

全球支架市场规模（按材料和复合年增长率划分）（2026-2033 年）

• 金属支架
• 非金属支架

全球支架市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 专科诊所
• 门诊手术中心
• 其他的

全球支架市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Boston Scientific
• Medtronic
• Abbott Laboratories
• Terumo Corporation
• Johnson & Johnson
• B. Braun Melsungen AG
• BIOTRONIK SE & Co. KG
• Cook Medical
• MicroPort Scientific Corporation
• Sahajanand Medical Technologies
• Alvimedica
• Biosensors International
• Lepu Medical Technology
• Meril Life Sciences
• Balton Sp. z oo
• Translumina Therapeutics
• Vascular Concepts
• Relisys Medical Devices
• Endocor GmbH
• Hexacath

结论与建议

Stents Market size was valued at USD 9.61 Billion in 2024 and is poised to grow from USD 9.92 Billion in 2025 to USD 12.87 Billion by 2033, growing at a CAGR of 3.3% during the forecast period (2026-2033).

The stent market is experiencing robust growth due to rising rates of coronary artery disease, which is a leading cause of mortality. Increased demand for advanced medical interventions, particularly drug-eluting stents, is propelling market expansion. Technological innovations are enhancing stent design and efficacy, while substantial investments from both private and government entities are bolstering healthcare research and development. Stents, ranging from plastic to metal, play a critical role in maintaining blood flow by alleviating blockages in arteries and preventing serious complications such as aneurysms. The combination of medical advancements and the growing prevalence of cardiovascular issues underscores the vital importance of stents in contemporary healthcare, promising ongoing opportunities for market stakeholders to address urgent patient needs effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Stents Market Segments Analysis

Global Stents Market is segmented by product, material, end user and region. Based on product, the market is segmented into vascular and non-vascular stents. Based on material, the market is segmented into metallic stents and non-metallic stents. Based on end user, the market is segmented into hospitals, specialty clinics,ambulatory surgery centersand others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Stents Market

The increasing incidence of cardiovascular diseases is a significant catalyst for the growth of the stent market. As the number of individuals affected by cardiovascular conditions rises globally, the demand for stents is expected to escalate. A heightened prevalence of chronic illnesses leads to a greater need for medical interventions, particularly percutaneous coronary procedures and peripheral vascular surgeries. With cardiovascular diseases being responsible for a substantial percentage of global fatalities, the urgency for effective treatment options becomes more pronounced. Consequently, as more patients require these advanced procedures, the stent market is poised to experience significant expansion in response to this growing healthcare need.

Restraints in the Stents Market

The stents market faces significant challenges due to stringent regulatory requirements that impede its growth. Various regulatory bodies have implemented extensive guidelines to ensure the safe and effective use of stents, necessitating thorough reviews of existing literature and pre-clinical animal studies before approval. The process is notably resource-intensive, requiring considerable time and financial investment since coronary stents are categorized as high-risk devices. Due to the associated risks, strict oversight is maintained over stent usage, further complicating market dynamics. The classification of these devices as medium to high-risk entities adds to their regulatory burdens, ultimately dampening market demand.

Market Trends of the Stents Market

The stents market is experiencing significant growth driven by a wave of continuous product innovations and enhancements aimed at improving patient outcomes. Key advancements focus on reducing stent strut thickness to enhance flexibility and deliverability in complex vascular anatomies, alongside the introduction of longer lengths and smaller diameters to optimize percutaneous coronary interventions (PCI). This dynamic trend underscores the industry's commitment to refining stent designs, addressing procedural challenges, and elevating the overall patient experience. As manufacturers invest in research and development to meet the evolving needs of healthcare providers and patients, this trajectory is expected to facilitate robust market expansion in the years to come.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Trade Analysis

Global Stents Market Size by Product & CAGR (2026-2033)

• Market Overview
• Vascular
  • Coronary Stents
  • Peripheral Stents
  • Iliac Artery Stents
  • Femoral Artery Stents
  • Carotid Artery Stents
  • Renal Artery Stents
  • Other Peripheral Stents
  • Neurovascular Stents
  • Intracranial Stents
  • Flow Diverters
• Non-Vascular Stents
  • Gastrointestinal Stents
  • Biliary
  • Duodenal
  • Colonic
  • Pancreatic
  • Esophageal Stents
  • Pulmonary (Airway) Stents
  • Silicone Airway
  • Metallic Airway
  • Urological Stents
  • Others

Global Stents Market Size by Material & CAGR (2026-2033)

• Market Overview
• Metallic Stents
• Non-Metallic Stents

Global Stents Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Ambulatory Surgery Centers
• Others

Global Stents Market Size & CAGR (2026-2033)

• North America (Product, Material, End User)
  • US
  • Canada
• Europe (Product, Material, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Material, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Material, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Material, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Boston Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sahajanand Medical Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alvimedica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosensors International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balton Sp. z o.o.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Translumina Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascular Concepts
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Relisys Medical Devices
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endocor GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hexacath
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations